Weili Wang

Weili Wang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2022 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
THTianzhen Hu
Tianzhen Hu
CPChengyun Pan
Chengyun Pan
TZTianzhuo Zhang
Tianzhuo Zhang
MNMing Ni
Ming Ni
WWWeili Wang
Weili Wang
QFQin Fang
Qin Fang
Drug resistance is a key factor in the treatment failure of acute myeloid leukemia (AML). Nuclear factor E2-related factor 2 (Nrf2) plays a crucial role in tumor chemotherapy resistance. However, the potential mechanism of Nrf2 regulating DNA mismatch repair (MMR) pathway to mediate gene-instability drug resistance in AML is still unclear. Here, it was found that Nrf2 expression was closely related to the disease progression of AML as well as highly expressed in AML patients with poor prognostic gene mutations. Meanwhile, it was also found that the expression of Nrf2 was significantly negatively correlated with DNA MMR gene replication factor C4 (RFC4) in AML. CHIP analysis combined with luciferase reporter gene results further showed that Nrf2 may inhibit the expression of RFC4 by its interaction with the RFC4 promoter. In vitro and vivo experiments showed that the overexpression of Nrf2 decreased the killing effect of chemotherapy drug cytarabine (Ara-C) on leukemia cells and inhibited the expression of RFC4. Mechanistically, The result that Nrf2-RFC4 axis mediated AML genetic instability drug resistance might be received by activating the JNK/NF-κB signaling pathway. Taken together, these findings may provide a new idea for improving AML drug resistance.

2 September 2020 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
JXJie Xiong
Jie Xiong
XKXingyi Kuang
Xingyi Kuang
TLTingting Lu
Tingting Lu
KYKunlin Yu
Kunlin Yu
XLXu Liu
Xu Liu
JWJishi Wang
Jishi Wang

26 April 2025 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
SLShen-Sui Li
Shen-Sui Li
XTXu-Dong Tian
Xu-Dong Tian
JSJu-Kun Song
Ju-Kun Song
YWYa-Dong Wu
Ya-Dong Wu
WWWeili Wang
Weili Wang
JWJin-Bo Wang
Jin-Bo Wang
The safety of agricultural products is significant to human health. Pyraclostrobin (PYR), a common methoxycarbonyl fungicide, is a crucial role in the prevention of fungal infections during the transport and storage of agricultural products, including vegetables and fruits. Using a multi-analytical approach, integrating toxicological database mining, protein-protein interaction (PPI) network analysis, and molecular docking, this study aimed to elucidate the molecular mechanisms underlying the toxicity of PYR. A total of 162 and 129 targets were identified for cancer and kidney injury, respectively, with PPI analysis pinpointing five vital targets per condition. Functional enrichment through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genome (KEGG) pathway annotations revealed significant associations with pathways related to prostate cancer and renal impairment pathways. Molecular docking confirmed PYR's binding affinity to these targets, indicating its potential role in disease pathogenesis. Our findings underscore the imperative for stringent safety assessments of PYR, particularly concerning the risks posed by chronic exposure, and emphasize the urgency for further research to inform public health and environmental policies.

29 August 2022 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
THTianzhen Hu
Tianzhen Hu
CPChengyun Pan
Chengyun Pan
TZTianzhuo Zhang
Tianzhuo Zhang
MNMing Ni
Ming Ni
WWWeili Wang
Weili Wang
QFQin Fang
Qin Fang

8 May 2025 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
THTianzhen Hu
Tianzhen Hu
CPChengyun Pan
Chengyun Pan
TZTianzhuo Zhang
Tianzhuo Zhang
MNMing Ni
Ming Ni
WWWeili Wang
Weili Wang
QFQin Fang
Qin Fang

5 July 2021 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
JXJie Xiong
Jie Xiong
XKXingyi Kuang
Xingyi Kuang
TLTingting Lu
Tingting Lu
KYKunlin Yu
Kunlin Yu
XLXu Liu
Xu Liu
JWJishi Wang
Jishi Wang